ENVUE MEDICAL INC NEW
FEED
FEED was delisted on the 15th of September, 2026.
11 hedge funds and large institutions have $1.72M invested in ENVUE MEDICAL INC NEW in 2021 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 7 closing their positions.
200% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 1
0.74% more ownership
Funds ownership: 5.19% → 5.92% (+0.74%)
27% less funds holding
Funds holding: 15 → 11 (-4)
33% less capital invested
Capital invested by funds: $2.58M → $1.72M (-$854K)
57% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 7
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$464K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$143K |
| 3 |
AFS
Amtrust Financial Services
New York
|
+$107K |
| 4 |
Morgan Stanley
New York
|
+$107K |
| 5 |
Goldman Sachs
New York
|
+$71.4K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Two Sigma Investments
New York
|
-$214K |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$84K |
| 3 |
Bank of New York Mellon
New York
|
-$69K |
| 4 |
XT
XTX Topco
George Town,
Cayman Islands
|
-$64K |
| 5 |
Squarepoint
New York
|
-$57K |
FEED Hedge Fund Activity: Q4 2021 in Review
11 of the 6,519 institutional investors tracked by Wall St. Rank reported a position in ENVUE MEDICAL INC NEW (FEED) for Q4 2021, worth a combined $1.72M — down 33% from $2.58M a quarter earlier.
Sellers outnumbered buyers: 7 funds closed out of FEED and 3 opened new positions — a net loss of 4 holders — while 1 trimmed existing stakes and 3 added.
The largest buyer was Renaissance Technologies, opening a new position worth an estimated $464K. The largest seller was Two Sigma Investments, exiting entirely with an estimated $214K sold.
- 11 institutional investors held ENVUE MEDICAL INC NEW (FEED) as of Q4 2021, down from 15 in Q3 2021.
- Funds reported $1.72M of ENVUE MEDICAL INC NEW stock for Q4 2021, down 33% quarter-over-quarter.
- 3 funds opened new ENVUE MEDICAL INC NEW positions in Q4 2021 and 7 closed out, a net change of -4 holders.
- The largest ENVUE MEDICAL INC NEW buyer in Q4 2021 was Renaissance Technologies, an estimated $464K added.
- The largest ENVUE MEDICAL INC NEW seller in Q4 2021 was Two Sigma Investments, an estimated $214K sold.
Based on aggregated 13F filings for Q4 2021.